US Weight-Loss Drug Prescriptions in Children Under 12 Surge 300-Fold

A study reports a 300-fold increase in prescriptions for weight-loss medications among US children under 12, indicating a significant shift in pediatric obesity treatment. The finding raises questions about long-term safety and off-label use, as these drugs are not widely approved for this age group. This trend could prompt regulatory scrutiny and public-health debate.